Chengdu Kanghong Pharmaceutical Group Co., Ltd

Shenzhen Stock Exchange 002773.SZ

Chengdu Kanghong Pharmaceutical Group Co., Ltd Price to Book Ratio (P/B) on January 14, 2025: 2.15

Chengdu Kanghong Pharmaceutical Group Co., Ltd Price to Book Ratio (P/B) is 2.15 on January 14, 2025, a 6.91% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Chengdu Kanghong Pharmaceutical Group Co., Ltd 52-week high Price to Book Ratio (P/B) is 2.75 on October 08, 2024, which is 27.77% above the current Price to Book Ratio (P/B).
Chengdu Kanghong Pharmaceutical Group Co., Ltd 52-week low Price to Book Ratio (P/B) is 1.60 on February 05, 2024, which is -25.78% below the current Price to Book Ratio (P/B).
Chengdu Kanghong Pharmaceutical Group Co., Ltd average Price to Book Ratio (P/B) for the last 52 weeks is 2.26.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 002773.SZ

Chengdu Kanghong Pharmaceutical Group Co., Ltd

CEO	Mr. Xiao Ke
IPO Date	June 29, 2015
Location	China
Headquarters	No.36, Shuxi Road
Employees	4,289
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Chengdu Kanghong Pharmaceuticals Group Co., Ltd engages in the research, development, production, and sale of biological products, Chinese medicines, and chemical drugs in China. It offers ophthalmic systems, central nervous systems, digestive systems, and other system drugs. The company was founded in 1996 and is headquartered in Chengdu, China.

Key trends

Past 5 years